These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 36761106)

  • 1. Virus-Like Cytosolic and Cell-Free Oxidatively Damaged Nucleic Acids Likely Drive Inflammation, Synapse Degeneration, and Neuron Death in Alzheimer's Disease.
    Sanders OD
    J Alzheimers Dis Rep; 2023; 7(1):1-19. PubMed ID: 36761106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does oxidatively damaged DNA drive amyloid-β generation in Alzheimer's disease? A hypothesis.
    Sanders OD; Rajagopal L; Rajagopal JA
    J Neurogenet; 2021; 35(4):351-357. PubMed ID: 34282704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oxidatively damaged DNA and amyloid-β oligomer hypothesis of Alzheimer's disease.
    Sanders OD; Rajagopal L; Rajagopal JA
    Free Radic Biol Med; 2022 Feb; 179():403-412. PubMed ID: 34506904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β
    Ebrahimi T; Rust M; Kaiser SN; Slowik A; Beyer C; Koczulla AR; Schulz JB; Habib P; Bach JP
    J Neuroinflammation; 2018 Sep; 15(1):282. PubMed ID: 30261895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease.
    Austad SN; Ballinger S; Buford TW; Carter CS; Smith DL; Darley-Usmar V; Zhang J
    Acta Pharm Sin B; 2022 Feb; 12(2):511-531. PubMed ID: 35256932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification.
    Izzo NJ; Yuede CM; LaBarbera KM; Limegrover CS; Rehak C; Yurko R; Waybright L; Look G; Rishton G; Safferstein H; Hamby ME; Williams C; Sadlek K; Edwards HM; Davis CS; Grundman M; Schneider LS; DeKosky ST; Chelsky D; Pike I; Henstridge C; Blennow K; Zetterberg H; LeVine H; Spires-Jones TL; Cirrito JR; Catalano SM
    Alzheimers Dement; 2021 Aug; 17(8):1365-1382. PubMed ID: 33559354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.
    Ahmed ME; Iyer S; Thangavel R; Kempuraj D; Selvakumar GP; Raikwar SP; Zaheer S; Zaheer A
    J Alzheimers Dis; 2017; 60(3):1143-1160. PubMed ID: 28984607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nucleotide-binding Oligomerization Domain-like Receptor Family Pyrin Domain Containing 3 Inflammasome in Alzheimer's Disease].
    Feng YY; Chen H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):788-795. PubMed ID: 34728041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of NLRP3 Inflammasome in Alzheimer's Disease and Potential Therapeutic Targets.
    Liang T; Zhang Y; Wu S; Chen Q; Wang L
    Front Pharmacol; 2022; 13():845185. PubMed ID: 35250595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial DNA damage triggers spread of Parkinson's disease-like pathology.
    Tresse E; Marturia-Navarro J; Sew WQG; Cisquella-Serra M; Jaberi E; Riera-Ponsati L; Fauerby N; Hu E; Kretz O; Aznar S; Issazadeh-Navikas S
    Mol Psychiatry; 2023 Nov; 28(11):4902-4914. PubMed ID: 37779111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's Disease and Protein Kinases.
    Engin AB; Engin A
    Adv Exp Med Biol; 2021; 1275():285-321. PubMed ID: 33539020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease.
    Yang J; Wise L; Fukuchi KI
    Front Immunol; 2020; 11():724. PubMed ID: 32391019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging Enables Ca2+ Overload and Apoptosis Induced by Amyloid-β Oligomers in Rat Hippocampal Neurons: Neuroprotection by Non-Steroidal Anti-Inflammatory Drugs and R-Flurbiprofen in Aging Neurons.
    Calvo-Rodríguez M; García-Durillo M; Villalobos C; Núñez L
    J Alzheimers Dis; 2016 Jul; 54(1):207-21. PubMed ID: 27447424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive Astrocytes Contribute to Alzheimer's Disease-Related Neurotoxicity and Synaptotoxicity in a Neuron-Astrocyte Co-culture Assay.
    Wasilewski D; Villalba-Moreno ND; Stange I; Glatzel M; Sepulveda-Falla D; Krasemann S
    Front Cell Neurosci; 2021; 15():739411. PubMed ID: 35126055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease.
    Zhang Y; Zhao Y; Zhang J; Yang G
    Neurochem Res; 2020 Nov; 45(11):2560-2572. PubMed ID: 32929691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation.
    Paterniti I; Cordaro M; Campolo M; Siracusa R; Cornelius C; Navarra M; Cuzzocrea S; Esposito E
    CNS Neurol Disord Drug Targets; 2014; 13(9):1530-41. PubMed ID: 25106636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.